The UK's vote to leave the European Union has come at a crucial moment in the development of an international medical project that throws into sharp relief the state of flux Brexit has cast over collaborative research, says Jack Barton.
A less strict approach on defining endocrine disruptors will help industries producing such substances “pollute and not pay”, the association representing Europe's water sector (EurEau) told EurActiv.com.
British retail spending bounced back in July as sales promotions and good weather outweighed any immediate concern about the consequences of Britain's decision to leave the European Union, a survey showed on Tuesday (8 August).
The European Commission's draft criteria for identifying endocrine disruptors in pesticides and biocides are "not sufficient" to protect people and the environment, the European chemical industry has warned.
The United Nations High-Level Panel on Access to Medicines does not address the actual problems of developing countries, such as inadequate infrastructure and shortage of medical staff, writes Dr. Barbara Kolm.
The debate over glyphosate has not been a scientific discussion but an activists’ war against ‘Big Agri’. Glyphosate is scientifically proven to be safe and should be re-authorised, writes André Heitz.
In the aftermath of the Brexit vote, Rome and Madrid are leading the race to gain the right to host influential EU agencies, while Croatia, Bulgaria, Cyprus, Romania and Slovakia could remain empty-handed.
The trade in illicit tobacco is a massive problem, but the European Commission has been presented with a golden opportunity to strike a blow against the smugglers. But it must look long-term, writes Eric Lequenne.
A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EurActiv.com
While HIV/AIDS still claims too many lives and causes suffering to millions of affected people and their loved ones across the world, substantial progress has been recorded to put an end to the epidemic, write Tim Wilsdon and Lilian Li.
The European Commission intends to widen the scope for energy drink makers to advertise their products, but consumer protection activists have voiced concerns about misleading health claims and their effect on young people. EurActiv Germany reports.